Results 91 to 100 of about 222 (145)

Repolarization adaptation to rapid change in heart rate in human models – a review

open access: yesThe Journal of Physiology, Volume 604, Issue 16, Page 6675-6690, 15 August 2026.
Abstract figure legend This review focuses on non‐invasive assessment of repolarization duration and dispersion (heterogeneity) adaptation to change in heart rate (HR). HR was increased incrementally by left atrial pacing during an electrophysiology (EP) study and by a bolus injection of atropine and in a step up/down fashion by repeated right atrial ...
Lennart Bergfeldt   +5 more
wiley   +1 more source

Cardiac arrest due to acquired long QT syndrome during gynecologic laparoscopy: a case report

open access: yesFrontiers in Medicine
BackgroundAcquired long QT syndrome (aLQTS) is a disorder of delayed myocardial repolarization induced by medications, electrolyte disturbances, and other factors, with a significantly higher risk in females than in males.
Wenwen Wang   +3 more
doaj   +1 more source

Acquired Long-QT Syndrome: Mild but Abnormal?

open access: yesInternal Medicine, 2018
Kashiwa, Asami, Aiba, Takeshi
openaire   +3 more sources

QT Prolongation and Acquired Long QT Syndrome in Climbers on Mount Everest

open access: yesJACC: Clinical Electrophysiology
Pilgrim, Thomas   +9 more
openaire   +2 more sources

Acquired Long QT Syndrome in a Young Patient with Cerebral Contusion

open access: yesIndian Heart Journal
Debasis Panda   +6 more
doaj   +1 more source

Acquired long QT syndrome in hospitalized patients

Heart Rhythm, 2017
Acquired long QT syndrome (ALQTS) has long been overlooked in clinical practice. Recent studies reported that severe ALQTS (QTc ≥500 ms) in hospitalized patients is associated with increased all-cause mortality.The purpose of this study was to determine the role of ALQTS in the clinical outcomes of hospitalized patients.Electronic medical records were ...
, , Jie Du
exaly   +3 more sources

Pharmacogenomics and acquired long QT syndrome

Pharmacogenomics, 2005
During the past decade pharmaceutical companies have been faced with the withdrawal of some of their marketed drugs because of rare, yet lethal, postmarketing reports associated with ventricular arrhythmias. The implicated drugs include antiarrhythmics, but also non-cardiac drugs, such as histamine blockers, antipsychotics, and antibiotics.
Aerssens, J.M.M.R., Paulussen, A.D.
exaly   +4 more sources

Home - About - Disclaimer - Privacy